Diabetes and Epigenetics

Epigenetics, the study of changes in gene expression without altering the underlying DNA sequence, is increasingly recognized as a key factor in the development and progression of diabetes. Environmental factors such as diet, stress, and exposure to toxins can influence gene expression through epigenetic mechanisms, potentially increasing the risk of insulin resistance and Type 2 Diabetes. For example, modifications like DNA methylation and histone modification can affect genes involved in glucose metabolism and insulin sensitivity. Research is exploring how epigenetic changes can be reversed or modified to prevent or treat diabetes. This growing field offers potential for personalized treatments based on an individual's epigenetic profile, paving the way for more targeted and effective interventions.

    Related Conference of Diabetes and Epigenetics

    March 26-27, 2026

    7th Global summit on Diabetes and Endocrinology

    Amsterdam, Netherlands
    May 14-15, 2026

    7th World Summit on Diabetes

    Rome, Italy
    May 18-19, 2026

    57th Annual Congress on Endocrinology and Diabetes Research

    Aix-en-Provence, France
    June 22-23, 2026

    16th World Congress on Endocrinology and Diabetes

    Paris, France
    August 17-18, 2026

    4th World congress and Expo on Diabetes

    Toronto, Canada
    September 29-30, 2026

    22nd World Congress on Endocrinology & Diabetes

    Paris, France

    Diabetes and Epigenetics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in